PharmaCyte Biotech, Inc. PMCB
0.34 USD +0.02 +6.35%
As of Nov 3, 12:48 PM ET
0.3021 52-week range 1.51
- YTD
- -53.73%
- 1 year
- -63.48%
- Open
- 0.3164
- Prev close
- 0.315
- Mkt cap
- 3.60M
- Vol
- 6.90K
- Avg vol
- 183.73K
- EPS
- -2.31
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.3164
- High
- 0.335
- Forward P/E
- -4.21
- Beta
- -0.20
- Short ratio
- 1.09
- Inst. own
- 13.16%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.73
- 200-d avg
- 1.94
- 1y target
- 0.00
5D chart
Chart tools
Chart is warming up
The five-day price history for PMCB has not been loaded yet. Try again in a moment.
Altman Z-Score
-3.39 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
P/E -0.3×
P/S 0.0×
P/B 0.2×
P/FCF -1.0×
EV/EBITDA 2.6×
EV/Sales 0.0×
FCF Yield -101.8%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -58.3%
ROIC -14.9%
ROA -41.5%
Revenue 0.0%
Operating Income -56.6%
EPS (diluted) -186.8%
Free Cash Flow -73.0%
Current Ratio 45.3×
Quick Ratio 45.3×
Debt / Equity 0.0×
Net Debt / EBITDA 3.5×
Interest Coverage 0.0×
Dividend Yield 4.9%
Payout Ratio -1.3%
Annual · latest fiscal year ends 2026-04-30
